We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

SARSTEDT AG+CO KG

Sarstedt provides laboratory and medical equipments, and develops, manufactures and sells equipment and consumables i... read more Featured Products: More products

Download Mobile App




Antibody Levels in Saliva Associated with Risk of Mortality

By LabMedica International staff writers
Posted on 05 Jan 2016
Print article
The Salivette collection device for saliva samples
The Salivette collection device for saliva samples (Photo courtesy of SARSTEDT AG+CO KG)
Immunoglobulins (Ig) or antibodies are proteins secreted by white blood cells (B lymphocytes), which circulate in the body and tag, destroy, and/or neutralize bacteria, viruses, and other harmful or foreign materials, the antigens.

Secretory IgA (sIgA) is secreted at the mucosal surfaces such as the mouth, nose, gastrointestinal tract, and can be measured in saliva. SIgA is the first line of defense against infection at these surfaces, acting to prevent colonization by microbes. It is considered particularly key in the defense against viral and bacterial infections of the upper respiratory tract (URTIs), such as colds and influenza.

Scientists at the University of Birmingham (Edgbaston, UK) and their colleagues collected saliva and data derived from the oldest of three age cohorts in the West of Scotland. Of the 1,042 participants who took part in the first wave of the study, 723 were re-interviewed at the third wave, the baseline for the analysis; 91 participants died before wave three leaving 951 participants eligible for participation. Participants were interviewed in their own homes by nurses who were trained in a standardized manner in how to administer a standardized interview schedule and collect the saliva sample.

Saliva samples were taken at the end of the interview but before taking any other physical measures using a standard salivette (Sarstedt Ltd., Leicester, UK). All samples were frozen within two hours of collection and remained frozen at -20 °C until assay. Samples were recovered after thawing by centrifugation at 1,000 g for 10 minutes. Secretory IgA concentration was measured by double antibody sandwich enzyme-linked immunosorbent assay (ELISA). The 639 participants' saliva was sampled in 1995 when they were aged 63 years. Their IgA secretion rate was measured and the mortality rate was tracked over the following 19 years.

The team found that there was a negative association between log sIgA secretion rate and all-cause mortality. Further analysis of specific causes of mortality revealed that the all-cause association was due to an underlying association with cancer mortality and in particular with cancers other than lung cancer. The hazard-ratio (HR) for non-lung cancer was 0.68 implying a 32% reduction in mortality risk per standard deviation rise in log sIgA secretion rate. Higher secretion rates of sIgA were associated with a decreased risk of death from cancer, specifically non-lung cancer, as well as from respiratory disease. Thus, it appears that sIgA plays a protective role among older adults, and could serve as a marker of mortality risk, specifically cancer mortality.

Anna C. Phillips, PhD, the lead author of the study, said, “There are a number of factors that can affect how well we produce antibodies and maintain their levels. It is not yet known how saliva samples could be used in checkups, as scientists have yet to establish what secretion rate would be considered the threshold level before becoming a cause of concern, otherwise known as the "protective level. If the level is very low, this could be considered a useful early indicator of risk.” The study was published on December 23, 2015, in the journal Public Library of Science ONE.

Related Links:

University of Birmingham 
Sarstedt Ltd. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.